“Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NFκBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats,” by Sahar S. Abd El-Rahman and Hany M. Fayed (PLoS ONE 17(3): e0265961. doi.org/10.1371/journal.pone.0265961, XML, HTML, and .pdf format, 21p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0265961
